Trials that involve new drugs being compared to existing versions could let inferior treatments slip through.
Genetic tests can be fraught with false positives and insignificant findings that may undermine their effectiveness.
Critics say a certain type of statement allowed on food labels could mislead—rather than inform—consumers.
A movement to ban uncredited contributors is growing among medical journals.
Pharmaceutical companies are finding that reducing waste in drug manufacturing can also save them millions of dollars.
Some drugs lend extreme wakefulness and focus—but are the enhancements worth the risks?
Getting the various pieces of operating room equipment to communicate with one another could save lives—but it’s easier said than done.
Scientists have had only a glimmer of an idea how microbes affect our bodies; a $115 million National Institutes of Health project aims to find out.
The radioactive isotope, used in some 20 million medical scans each year, briefly found itself amid controversy.
No Articles Found.